European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer. Marguet, S.; Mazouni, C.; Ramaekers, B. L.; Dunant, A.; Kates, R.; Jacobs, V. R.; Joore, M. A.; Harbeck, N.; Bonastre, J.. Eur J Cancer. 2016; 168-79: p.168-79. doi:10.1016/j.ejca.2016.05.013 10.1016/j.ejca.2016.05.013. Epub 2016 Jun 17.Article
Oncostat